|
GLP-1 Receptor Agonists Clinical Trials
2 actively recruiting trials
No change since July 2026
Also known as: GLP-1/GIP dual agonists
Pipeline
Phase 4: 1
Top Sponsors
- The First Affiliated Hospital with Nanjing Medical University1
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
Indications
- Diabetes2
- Sarcopenic Obesity1
- Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)1
- Heart Disease1
- Obesity & Overweight1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.